Previously, ginsenoside Rg3 was reported to attenuate cerebral ischemia‒reperfusion injury by mitigating mitochondrial oxidative stress via the Nrf2/HO-1 signaling pathway [29]. This evidence concerns the gene HMOX1 and brain ischemia.